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BACKGROUND Treating temporal volume loss for aesthetic and reconstructive purposes can be
achieved by superficial or deep injections of soft tissue fillers into the temples. The latter is
performed with bone contact that can lead to intracranial penetration when the bone is accidentally
penetrated.
OBJECTIVE Based on a clinical case, the potential risk of accidental intracranial penetration was investigated.
MATERIALS AND METHODS Twenty fresh-frozen hemi-faces (all Caucasian ethnicity, 10 women,
10 men, mean age 72.8 6 11.2 years) were investigated. Shape of pterion and bone-stability
parameters of the temporal fossa were investigated. Bone stability was tested using uniaxial mechani-
cal indentation (18-G, 1.25-mm diameter, 15-mm length blunt-tip device) until intracranial perforation
occurred.
RESULTS Variations in the shape of the pterion, bone thickness, and density correlates were detected,
however, without statistical significant differences in side symmetry. Minimum force necessary to penetrate
intracranially was 40.4 N.Maximum force generated by an 18-g, 70-mm length blunt-tip cannula was 32.16 4.2 N
in 70 mm length and 75.3 6 10.2 N in 15 mm length.
CONCLUSION Based on the results of this investigation, it can be concluded that there is a risk for intracranial
penetration performing the deep temple injection technique with direct pressure on the bone.
The authors have indicated no significant interest with commercial supporters.
Nonsurgical approaches to reduce the signs offacial aging using soft tissue fillers are a steadily
growing area of interest for dermatologic and
other aesthetic practitioners.1 The increasing
demand and popularity of these new therapeutic
options has led to an increase in the application of soft
tissue fillers between 2000 and 2016 by 298%.2 At the
present time, 24 different soft tissue fillers have been
approved by the U.S. Food and Drug Administration
for various facial applications.3
Treatment options for the temporal region include the
restoration of temporal volume loss, which can result
from skin laxity, temporalis muscle atrophy,4 and/or
from atrophy of the superficial and deep temporal fat
pads.5 This presents clinically with a more prominent
appearance of the temporal crest, the lateral superior
orbital ridge, and the zygomatic arch.6,7
Techniques for treating temporal volume loss are
primarily based on the injection of soft tissue fillers
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into 2 different planes: superficial—into the sub-
cutaneous plane, superficial to the superficial temporal
artery and themotor branches of the facial nerve—and
deep—into the temporalis muscle, in contact with the
bone and deep to the motor branches of the facial
nerve and deep to the middle zygomatico-temporal
vein (sentinel vein).8–10 However, severe complica-
tions have been reported when treating the temple of
which irreversible blindness is considered the worst of
any potential outcome.11–13 The true causes for this
complication remain elusive, but explanatory models
include intravascular injection of the material with
ultimate occlusion of the retinal artery.11 To avoid this
potential risk, deep supra-periosteal injections, in
contact with the bone, were recommended.11,14
The underlying bone in this area is known as the pte-
rion andhas been shown to vary in shape as it is a point
of convergence of the sutures between the frontal,
sphenoid, parietal, and squamous temporal bones.15–
18 This variability of bone morphology can result in
a reduction of bone stability giving rise to the potential
risk of intracranial penetration during deep temporal
augmentation procedures.
Inspired by a clinical case of potential intracranial
penetration that occurred after a temporal augmen-
tation procedure, the objectives of the present study
were the following:
(1) To describe a clinical case where accidental
intracranial penetration is suspected
(2) To measure bone stability parameter of the
temporal fossa and
(3) To reproduce the clinical scenario (presented in
the case report) using an 18-G, 70-mm blunt-tip
cannula.
Clinical Case
Bilateral temporal augmentation of a 48-year-old
healthy woman without previous neurological signs or
symptoms was performed in an external clinic using
a commercially available soft tissue filler (Juvederm
Volumawith Lidocaine, Allergan, Dublin, Ireland). The
box contained 2 syringes of the volumizing product, 2
single-use 23-G, 1$ U.T.W. (Ultra Thin Wall) needles,
and 2 single-use, 18-G, 70-mm cannulae. The injection
was first performed on the right side using the deep
injection technique: skin perforation of the temple was
performed using the 23 G, 1$ needle at the temporal
skin–hairline border approximately at the horizontal
level of the lateral canthus.After the skinwaspenetrated,
the needle was removed and the 18-G, 70-mm blunt-tip
cannula was inserted into deeper layers. When being in
contact with the bone, additional pressure was experi-
enced by the patient followed by a sudden loss of resis-
tance and a pain-free breakthrough sensation. When
treating the contralateral side, a slight burning sensation
started which intensified during the next 3 hours. Three
hours after the injection, slight bruising and right-sided
headache started. The following day, nausea, stiffness of
the neck, severe headache, and complete bruising of the
temporal region were present (Figure 1). No central or
peripheral neurological deficiencies were experienced by
thepatient.Oral corticosteroids andanalgesicswere self-
administered, but no hyaluronidase was injected. Mag-
netic resonance imaging and computer tomographic
imaging 8 days after the injection revealed no definite
evidence for intracranial penetration, but local signs of
dural inflammation in the area of the injection were
diagnosed with no affection of the fronto-insular cortex
orpresenceof anyother pathology. Fourteenweeks after
injection, general symptoms cleared almost completely
and the follow-up magnetic resonance imaging (MRI)
scan revealed local dural thickening; thiswas interpreted
as suspect of a highly differentiated glioma (Figure 1).
Eighteen weeks after injection, another follow-up MRI
scan showed a hypointense, cortical signal alteration
indicative of a previous local corticocerebral inflamma-
tion. No evidence for glioma in a C11 methionin posi-
tron emission tomography scan was noted 22 weeks
after the injection procedure. The final radiological
report 14 months after the injection described a heredi-
tary local disregulation of the gray–white matter differ-
entiation as the most probable cause when summarizing
the imaging-based findings. Albeit accidental intracra-
nial injection of soft tissuefillerwas considered as a valid
explanatory model for the imaging-based findings, this
was not concluded in the written record because of the
lack of magnetic resonance reference data, the unique-
ness of the case and because of the lack of experience
with injectable related complications. Up to date, the
patient never experienced any central or peripheral
neurological deficiency, but still perceives intermittent
PH I L I P P -DORMSTON ET AL
44 : 1 : J ANUARY 20 1 8 85
© 2017 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
headaches and postural unilateral pain of the temporal
region.
Materials and Methods
Based on the presented clinical case, a biomechanical
investigation was conducted to simulate the clinical
scenario using the same cannula size and length, to
evaluate if intracranial penetration is possible in
a testing environment, and to provide valid data for
the possibility of intracranial penetration when using
soft tissue fillers applying with the deep injection
technique.
Study Sample
Twenty fresh-frozen, not embalmed hemi-faces of 10
Caucasian human body donors (5 women and 5 men)
with a mean age at death of 72.86 11.2 years (range
49–88) and a body mass index of 27.36 6.2 kg/m2
(range 19.9–38.1) were investigated. None of the body
donors was diagnosed while alive with plasmacytoma
norhadadocumenteduptakeofbisphosphonates.Two
(1 man and 1 woman) were diagnosed while alive with
osteoporosis, whereas 7 had a positive medical history
for smoking. While alive, all body donors gave
informed consent for their bodies to be used formedical
education and for purposes of scientific investigation.
Selection of Measured Locations
Each of the hemi-faces was freed from soft tissues
within the area of interest using sharp anatomical
dissection. The shape of the pterion was identified and
documented. Four different measuring points for
mechanical testing were selected and marked on the
bone in relation to the lateral canthus based on the
most frequently used locations for temporal augmen-
tation procedures: A1: 2 cm posterior and 2 cm
superior to the lateral canthus, A2: 2.5 cm posterior
and 2 cm superior to the lateral canthus, B1: 2 cm
posterior and 1 cm superior to the lateral canthus, and
B2: 2.5 cm posterior and 1 cm superior to the lateral
canthus (Figure 2).
Mechanical Testing
Mechanical testing relied on uniaxial mechanical
compression using a static material testing machine
(Z5.0; Zwick/Roell, Ulm, Germany). Mechanical
compression was performed perpendicular to the
surface of the bone at the 4 marked measuring
points (A1, A2, B1, B2) using an 18-G, 15-mm
solid, blunt-tipped wire as an indentation device.
Indentation was carried out until penetration of the
bone and access to the intracranial space was ach-
ieved or until the maximal producible load of the
testing machine (here 480 Newton [N]) was
exceeded.
Additionally, the maximal force generated by an 18-
G, 70-mm blunt-tip cannula (INEX, Puiseux-
Le-Hauberger, France) was measured (Figure 3)
using the same uniaxial compression set-up. As the
distance between the bone and the strong,
Figure 1. Clinical (A) and magnetic resonance image (B) of the presented case showing a hematoma of the right temporal
region as well as increased thickness of the subcutaneous structures as compared to the contralateral side.
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fibrous deep temporal fascia was measured to be in
mean 15 mm in the tested region, the cannula was
cut to a size of 15 mm and the generated forces were
measured for this length as well. Transcortical bone
thickness was manually measured in each of the 4
mechanical testing locations after each indentation
procedure.
Translumination Analyses
Bone density correlates of the hemisected cephalic
specimens were measured from standardized pictures
taken with a standard digital camera (EOS, 450D;
Cannon, Tokyo, Japan) with fixed adjustment for
exposure time, focus, sensitivity to light, and dia-
phragm during translumination. Pseudo-color gray-
value analysis of the obtained images was performed
using ImageJ software (National Institutes of Health,
Sacaton, AZ) with values ranging from 0 (black) to
1,000 (brightwhite). Pseudo-color gray-value analysis
was performed at the 4 points used for mechanical
testing and at 3 additional randomly selected points.
These, too, were in relation to the lateral canthus: C1:
5 cm posterior and 0 cm superior, C2: 5 cm posterior
and 2 cm superior, and C3: 5 cm posterior and 4 cm
superior (Figure 2).
Statistical Analyses
To show the variability of the bones of the temporal
region, the shape of the pterionwas classified andbone
density correlates measured at the 7 points were cal-
culated and compared for sex and side differences
using a student t-test. Bone thickness and the maximal
force leading to intracranial penetration were mea-
sured and correlated using Pearson R correlation test.
The maximal force generated by the 18-G cannula in
both the 70-mm and 15-mm lengths was measured
Figure 2. Image of a transilluminated cephalic specimen
showing the 4 measuring points for uniaxial mechanical
compression: A1: 2 · 2 cm, A2: 2.5 · 2 cm, B1: 2 · 1 cm
and B2: 2.5 · 1 cm in posterior x superior relation to
the lateral canthus (red dot) at the level of the canthal
plane. Also, the 3 additional points for translumination
imaging using a monochromatic light source are
included which were used for the pseudo-color
gray-value analysis of the obtained images: C1: 5 · 0 cm,
C2: 5 · 2 cm and C3: 5 · 4 cm in posterior x superior
relation to the lateral canthus (red dot) at the level of the
canthal plane.
Figure 3. Panel A, showing the set-up of the indentation procedure using a solid, blunt wire (18 G [1.25 mm], 15 mm in
length) as indentation device. Panel B, showing the uniaxial mechanical compression of the 18-G, 70-mm blunt cannula for
measuring the maximal force generated on compression.
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and compared with the forces needed to penetrate
intracranially (Figure 3). Statistical analyses were
performedwith SPSS Statistics 23 (IBM,Armonk,NY)
and all applied tests were 2-sided, and p-values <.05
were considered as statistically significant to guide
conclusions.
Results
The shape of the pterion of the 20 hemi-faces was
sphenoparietal in 70% (n = 14), fronto-temporal in
5% (n = 1), and epipteric bones were present in 25%
(n = 5). No significant differences were detected
between sex (p = .75) or side (p = .75).
Bone density (as measured by pseudo-gray value
analysis) was 1566 10.9 units formen and 96.46 6.9
units for women (mean 6 SD) with a mean sex dif-
ference of 59.56 23.1 units (p= .004). Side differences
were without statistical significance (p = .55) with
a mean value of 10.2 6 19.8 units.
Overall bone thickness (independent of measured
location) was 4.526 2.01mm (range: 1.70–13.0mm)
with women having a thicker bone (5.606 2.25 mm)
as compared to men 3.43 6 0.92 mm (p = .01). No
significant side differences were detected for overall
thickness measures (p = .85) nor at each of the 4 (A1,
A2, B1, B2) individually measured points (p > .29).
Incomplete intracranial penetration resulted in 6
cases (3 women) as the maximal force capacity of the
testing machine (480 N) was exceeded because of
increased bone resistance independent of the inden-
tation sites (A1, A2, B1, B2). Overall, mean pene-
tration force (independent of indentation site) was
294 6 130 N (range: 40–480), whereas after
excluding the incomplete penetrated cases (n = 6) the
mean force overall was 216 6 53 N. The minimum
force to penetrate intracranially was 40.4 N (Figure 4)
which was measured 2.5 cm posterior and 1 cm
superior to the lateral canthus; (B2). A ranking of the
locations according to the minimal force needed for
intracranial penetration revealed the following: B2 <
A1<B1<A2 (2.5·1 cm, 2·2 cm, 2·1 cm, 2.5·2 cm;
all posterior · superior as measured from the lateral
canthus; Table 1).
A statistically significant correlation was identified
between bone thickness and applied force until intra-
cranial penetrationwas achieved r = 0.56 (p = .01), but
not between bone density and applied force until
intracranial penetration.
Themeanmaximal force thatwas generated by the 18-
G cannula was 32.1 6 4.2 N (range 27.0–38.6) in its
full length (70 mm), whereas at 15 mm in length, the
mean maximal force was 75.36 10.2 N (range 61.3–
85.9). These values were independent of the speed
during uniaxial mechanical compression (5, 20, 50
mm/s; data not shown).
Discussion
The objectives of this study were inspired by the events
of a clinical case which occurred after a temporal aug-
mentation procedure in which the volumizing material
was injected using the deep application technique, i.e.,
being in contact with the bone. The authors tested the
bone stability of the temporal fossa in selected locations
using an indentation device with identical dimensions
to those of the cannula used in the presented clinical
case (18-G, 70-mm blunt-tip). The authors also tested
themaximal force than canbe generatedby the cannula
used in the clinical case to reveal whether intracranial
penetration in this setting is possible.
Figure 4. Force (measured in Newton (N)/deformation
(measured in mm) diagram of the lowest measured force
needed for intracranial penetration, obtained at 2.5 · 1 cm
(posterior · superior) to the lateral canthus (B2): 40.4 N.
Wavy shape of the curve displays increased forces during
the penetration of the outer and inner cortical lamella of
the diploe of the respective bone.
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The pterion is a point of convergence of the sutures
between the frontal, sphenoid, parietal, and squamous
temporal bones.15 Deep to this bony landmark, the
anterior branch of the middle meningeal artery,19
Broca motor speech area (Brodmann area 44, 45),17
the Sylvian point (division of the stem of lateral sulcus
of the cerebral hemisphere into the anterior, ascend-
ing, and posterior limb),18 and the insula all can be
found intracranially deep to the pterion (Figure 5).
Bone thickness in this area varies between 1 mm and
5 mm and differences between sex and side have been
previously reported.17,19–21 The thickness measure-
ments are in line with these previous reports and the
novel concept to measure bone density by pseudo-
color gray-value analysis supported the data as we did
findvariations between sex and side (albeit statistically
not meaningful). It is of great clinical importance,
however, as each temporal region should be treated
carefully and differences in side or sex must be con-
sidered when treating each individual.
Previous studies have described cutaneous access
points for temporal augmentation procedures and
relied on cutaneous landmarks, such as the tail of the
eyebrow or the temporal hair line,22 whereas others
emphasized guidance based upon “one up, one over”
in relation to the temporal crest and the superior
orbital rim when promoting safe and effective injec-
tion locations.9 As cutaneous landmarks change with
age—because of skin laxity and changes in the hair-
line—or with other cosmetic procedures (change in
length or position of the eyebrow) or because of vari-
ation in the angulation of the needle/cannula when
penetrating the skin and deeper structures,9 it might be
TABLE 1. Measured Data on Bone Thickness, Bone Density (As Measured by Pseudo-Color Gray-Value
Analyses), and Bone Stability (i.e., the Force in Newton Needed to Penetrate Intracranially) of the 20
Investigated Hemi-Faces
n = 20
Bone Thickness/mm Bone Density/Units Bone Stability/N
Mean (SD) Range Mean (SD) Range Mean (SD) Range
A1 3.72 (2.5)* 1.9–13.0 136 (61)* 40–255 295 (132)* 126–480
A2 4.70 (2.4)* 1.7–12.0 121 (61)* 45–257 302 (137)* 110–480
B1 4.79 (1.8) 2.5–9.0 115 (67)* 11–264 300 (135)* 108–480
B2 4.86 (2.5)* 2.3–12.5 106 (64)* 10–285 279 (162)* 40–480
Overall 4.51 (2.0)* 1.7–13.0 126 (44)* 10–285 294 (130)* 40–480
Values are given for each measured point: A1: 2 · 2 cm, A2: 2.5 · 2 cm, B1: 2 · 1 cm and B2: 2.5 · 1 cm in posterior · superior relation to
the lateral canthus at the level of the mid-pupillary line and overall.
*Significant differences of values between sex. Note: no significant side differences were observed.
Figure 5. Left panel: external view of the 10 superimposed right cephalic specimens during transillumination using a uni-
focal light source, showing dense and less dense areas of the temporal region. The point of minimal bone resistance (as
measured in this investigation) was 2.5 · 1 cm (posterior · superior) to the lateral canthus (red mark, B2): 40.4 N. Right
panel: internal view of a right cephalic specimen showing the same location as indicated by the laser cross. Note the bony
impression of the course of the middle meningeal artery.
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potentially safer to rely on stable and easy-to-identify
landmarks to guide temporal augmentation proce-
dures. In the present investigation, the measurements
relied on such an easy-to-identify and stable bony
landmark—the lateral canthus in the horizontal plane
at the level of the pupil—and provided information on
bone stability in selected locations posterior (2 or 2.5
cm) and superior (1 or 2 cm) to the lateral canthus. The
location with the lowest bone stability was measured
to be 2.5 cm posterior and 1 cm superior to the lateral
canthus (Figure 5); here, 40.4 N was sufficient to
penetrate intracranially which is equivalent to a pres-
surization of 4.12 kilogram. During temporal aug-
mentation procedures, this point should be marked
and direct bone contact in this location, independent
of where the superficial structures were penetrated,
should be avoided.
In the experimental setting, the maximal force gener-
ated by the18-G, 70-mmblunt-tip cannulawas 38.6N
andwas lower when compared with the smallest force
needed to penetrate intracranially (40.4 N). However,
the investigated sample size relied only on 10 human
body donors and it can be suspected that with
increasing sample size the variation of minimal bone
stability increases and caseswith abone stability of less
than 40.4 N could be encountered. It also has to be
stated that the sample investigated was of Caucasian
ethnicity exclusively, had a mean age of 72.8 6 11.2
years (range 49–88) and had a positive tabacco history
in 70% of the cases, which potentially deviates from
the patients seen for temporal augmentation proce-
dures seen on a daily clinical basis.
In the testing scenario, we reduced the size of the
cannula to 15 mm in length and could measure
a maximal generated force of 85.9 N before defor-
mation of the cannula occurred. Increased cannula
stability can be further enhanced by the surrounding
structures of the puncturing canal, such as the tem-
poralis muscle, the strong fibrous deep temporal fas-
cia, and the superficial temporal fascia. Such an
increase in cannula stability (up to 85.9 N) and forces
greater than the minimal bone stability (40.4 N) can
lead to an increased risk of intracranial penetration.
These increased forces, however, can be achieved only
when the cannula is stable and placed perpendicular to
the bone surface. It should be however noted, that the
presented forces were generated in a testing scenario
andmight not re-create the actual anatomical forces at
play when injecting a live patient. Nevertheless, it is
recommended to approach the bone from a different
location than the skin perforation using angulation to
avoid a direct perpendicular approach. Doing so, will
reduce the direct forces onto the bone and can reduce
the risk of this potentially life-threatening complica-
tion. A location superior to the inferior temporal
septum seems to be a favorable one for skin penetra-
tion and access to deeper structures as no motor
branches of the facial nerve nor the superficial tem-
poral artery are identified here.5,8,9
The indentation device used in this study aswell as the
selected cannulae for measuring the mechanical
properties was both blunt and thick in diameter (1.25
mm). It can be suspected that using sharp devices or
devices with a smaller diameter, the applied forces
can surpass the bony stability of the temporal fossa
easily and the risk for intracranial penetration is
higher than in the tested scenarios. However, future
studies need to test these assumptions, which poten-
tially might lead to the development of pressure sen-
sitive devices for the application of soft tissue filler for
the temporal region when treating temporal volume
loss.
From the clinical perspective, this study tries to create
awareness for the potential risk of accidental intra-
cranial penetration. The performed experiments were
enrolled in a very specific setting andpotentially donot
reflect the injection procedures performed on a daily
routine. Albeit, very specific in its results, this study
also reveals that practitioners should be able to dif-
ferentiate between symptoms related to the injection
procedure itself or extracranial adverse events, such as
soreness, jaw pain, and headache and symptoms
related to intracranial penetration, such as nausea,
vomiting, and neck stiffness.
Conclusion
Based on the results of these analyses, it can be con-
cluded that there is a potential risk of intracranial
penetration when the deep injection technique is
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performed being in perpendicular orientation to the
bone surface. The measured variability in the shape of
the pterion as well as the differences in bone stability
between side and sex underline this risk. The synopsis
of the biomechanical measurements and the imaging-
based findings presented in the case report increase the
probability that intracranial penetration without
major neurological damage occurred in the clinical
case presented. Profound knowledge of the temporal
anatomy as well as the use of a gentle injection tech-
nique allowing periosteum contact, but no direct
pressure on the bone should be mandatory for physi-
cians treating this delicate region.
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